Previous 10 | Next 10 |
home / stock / mdp:cc / mdp:cc news
Mistango River Resources Inc (MIS:CNX) is expected to report for quarter end 2023-09-30 Forza Petroleum Limited (FORZ:CA) is expected to report for Q1 2024 Whitemud Resources Inc. (WMK:CA) is expected to report for quarter end 2023-09-30 Elemental Altus Royalties Corp. (ELE:CA) is exp...
MacDonald Mines Exploration Ltd. (BMK:CA) is expected to report for quarter end 2023-09-30 ARHT Media Inc. (ART:CA) is expected to report for Q3 2023 Arianne Phosphate Inc. (DAN:CA) is expected to report for quarter end 2023-09-30 EQB Inc. (EQB:CA) is expected to report $2.85 for Q3 2...
Alvopetro Energy Ltd. (ALV:CA) is expected to report $0.23 for Q3 2023 Martello Technologies Group Inc. (MTLO:CA) is expected to report for quarter end 2023-09-30 George Weston Limited (WN:CA) is expected to report for Q3 2023 EQB Inc. (EQB:CA) is expected to report $2.85 for Q3 2023 ...
Slate Office REIT (SOT.UN:CA) is expected to report $0.09 for Q3 2023 Excellon Resources Inc. (EXN:CA) is expected to report for Q1 2024 High Arctic Energy Services Inc. (HWO:CA) is expected to report for Q1 2024 Medexus Pharmaceuticals Inc. (MDP:CA) is expected to report $0.02 for Q2...
Medexus Pharmaceuticals Inc. (MDP:CA) is expected to report $0.02 for Q2 2024
Fiscal Q2 2024 revenue reflects a 9.4% increase over fiscal Q2 2023, demonstrating strong revenue growth and continued overall performance Management to host conference call at 8:00 AM Eastern time on Thursday, November 9, 2023 Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - Novemb...
Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - November 1, 2023) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Thursday, November 9, 2023 to discuss Medexus's results for its second fiscal quarter ended September 30, ...
Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - October 17, 2023) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to announce that, in connection with its recently completed bought-deal public offering ( Offering ) of units ( Units ), Medexus has issued an additional 508,...
Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - October 16, 2023) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) has made in cash the final maturity date payment of C$51.1 million (or approximately US$37.5 million) to Computershare Trust Company of Canada as trustee for holders of ...
Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - October 6, 2023) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to announce the closing of its bought-deal public offering of 3,389,900 units ( Units ) at a price of C$2.95 per Unit for aggregate gross proceeds to Medexus o...
News, Short Squeeze, Breakout and More Instantly...
Medexus Pharmaceuticals Inc. Company Name:
MDP:CC Stock Symbol:
TSXC Market:
Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - May 1, 2024) - Following a trial in January 2023, Canada's Federal Court has issued a judgment declining to uphold the Canadian patent for Metoject®. Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) and medac, licensor of Medexus's c...
Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - April 2, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to announce that company management will be participating in the 2024 Bloom Burton & Co. Healthcare Investor Conference from April 16 to 17, 2024. Event : ...
Expanded indication includes patients under 12 years of age, based on Phase 3/4 data demonstrating safety and efficacy in previously treated patients in this age group Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - March 26, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) to...